De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis

Published:2019-04-19 Issue:1 Volume:48 Page:1-10
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Angiolillo Dominick J.,Patti Giuseppe,Chan Kam Tim,Han Yaling,Huang Wei-Chun,Yakovlev Alexey^ORCID,Paek Dara,del Aguila Michael,Girotra Shalini,Sibbing Dirk

Funder

Sanofi

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-019-01860-7.pdf

Reference44 articles.

1. Levine GN, Bates ER, Bittl JA et al (2016) 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol 68:1082–1115. https://doi.org/10.1016/j.jacc.2016.03.513

2. Valgimigli M, Bueno H, Byrne RA et al (2017) 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 39:213–260. https://doi.org/10.1093/eurheartj/ehx638

3. Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ (2018) ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison. J Am Coll Cardiol 72:2915–2931. https://doi.org/10.1016/j.jacc.2018.09.057

4. Wiviott SD, Braunwald E, McCabe CH et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001–2015. https://doi.org/10.1056/NEJMoa0706482

5. Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045–1057. https://doi.org/10.1056/NEJMoa0904327

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis;European Heart Journal;2023-03-08

2. Impact of Close Surveillance on Dual-Antiplatelet Therapy Compliance in Myocardial Infarction Patients Post-Percutaneous Coronary Intervention;Cardiovascular Revascularization Medicine;2023-03

3. Abatement of potent P2Y12 antagonist-based dual antiplatelet therapy after coronary intervention: A network meta-analysis of randomized controlled trials;Frontiers in Cardiovascular Medicine;2023-01-12

4. Predictors of In-Hospital De-Escalation of P2Y12 Inhibitors to Clopidogrel in Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention;Cardiovascular Revascularization Medicine;2022-09

5. Efficacy and Safety of De-escalation of Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Meta-Analysis of Randomized Clinical Trials;Journal of Cardiovascular Pharmacology;2022-08